Krečak, I. & Lucijanić, M. (2022). Can we use platelet-to-lymphocyte ratio (PLR) to
differentiate JAK2-unmutated erythrocytosis from
polycythemia vera?. European Journal of Internal Medicine. doi: 10.1016/j.ejim.2022.09.023
Krečak, Ivan and Marko Lucijanić. "Can we use platelet-to-lymphocyte ratio (PLR) to
differentiate JAK2-unmutated erythrocytosis from
polycythemia vera?." European Journal of Internal Medicine, 2022. https://doi.org/10.1016/j.ejim.2022.09.023
Krečak, Ivan and Marko Lucijanić. "Can we use platelet-to-lymphocyte ratio (PLR) to
differentiate JAK2-unmutated erythrocytosis from
polycythemia vera?." European Journal of Internal Medicine (2022). https://doi.org/10.1016/j.ejim.2022.09.023
Krečak, I. and Lucijanić, M. (2022) 'Can we use platelet-to-lymphocyte ratio (PLR) to
differentiate JAK2-unmutated erythrocytosis from
polycythemia vera?', European Journal of Internal Medicine. doi: 10.1016/j.ejim.2022.09.023
Krečak I, Lucijanić M. Can we use platelet-to-lymphocyte ratio (PLR) to
differentiate JAK2-unmutated erythrocytosis from
polycythemia vera?. European Journal of Internal Medicine [Internet]. 2022 [cited 2024 September 30]. doi: 10.1016/j.ejim.2022.09.023
I. Krečak and M. Lucijanić, "Can we use platelet-to-lymphocyte ratio (PLR) to
differentiate JAK2-unmutated erythrocytosis from
polycythemia vera?", European Journal of Internal Medicine, 2022. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:458097. [Accessed: 30 September 2024]